Padagis LLC has appointed Sujeet Singh as Chief Growth Officer, leveraging his extensive experience in pharmaceutical leadership to drive strategic growth initiatives and expand the company’s healthcare product portfolio.
In his current role at Padagis LLC, Sujeet Singh is tasked with spearheading strategic initiatives aimed at enhancing the company’s offerings in the healthcare sector.
Prior to joining Padagis LLC, Sujeet held the position of Chief Portfolio Management Officer at Azurity Pharmaceuticals, where he developed strategic roadmaps for pipeline expansion and introduced innovative ideas across various therapeutic areas and lifecycle management processes.
Previously, Sujeet served as CEO and Board Member (Co-founder) at Calyptus Pharmaceuticals, Inc., where he led the company in successfully delivering sterile products to hospitals, community clinics, and retail pharmacies. He notably oversaw the successful launch of complex injectable products, contributing to the company’s growth and market presence.
Before his tenure at Calyptus Pharmaceuticals, Sujeet held the role of Vice President & Head of Strategic Portfolio & Business Development for North America Generics at Dr. Reddy’s Laboratories. In this capacity, he played a pivotal role in establishing a sustainable complex generics business, forging strategic collaborations with research and manufacturing partners, and mentoring R&D teams.
Earlier in his career, Sujeet gained valuable experience in corporate finance at Siemens India, Ltd., and developed skills in software engineering at Infosys.